Boardroom Alpha
Boardroom Alpha
RVSB · Current Report (Form 8-K) · Filed April 2, 2026

Riverview Bancorp Inc — Current Report (Form 8-K)

Form
8-K
Filed
April 2, 2026
Period
Mar 30, 2026
Ticker
RVSB
Accession
0000939057-26-000075
Boardroom Alpha · Filing insights

Riverview Bancorp and Riverview Bank appoint two new directors, expanding boards from eight to ten; backgrounds outlined in the press release.

About Riverview Bancorp Inc
Market cap
$103M
1Y TSR
+7.1%
3Y TSR
−0.9%
Board grade
C
Sector
Financial Services
CEO
Nicole Sherman
Last annual meeting: Aug 27, 2026 · View full Riverview Bancorp Inc profile →

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported): March 30, 2026

RIVERVIEW BANCORP, INC.
(Exact name of registrant as specified in its charter)

 
Washington
 
000-22957
 
91-1838969
 
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)

 
900 Washington Street, Suite 900, Vancouver, Washington
 
98660
 
(Address of principal executive offices)
 
(Zip Code)

Registrant’s telephone number, including area code:  (360) 693-6650

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions.
 
   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class 
 
Trading Symbol(s) 
 
Name of each exchange on which registered
Common Stock, Par Value $0.01 per share
 
RVSB
 
 The NASDAQ Stock Market LLC
  
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]



Item 5.02  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(d) Appointment of New Directors

On March 30, 2026, Riverview Bancorp, Inc. (the “Company”), and its financial institution subsidiary, Riverview Bank (the “Bank”), announced that their Boards of Directors have appointed Mr. Jon Girod and Mr. Kourosh Zamanizadeh to their respective Boards of Directors effective March 30, 2026.  The appointment of Messrs. Girod and Zamanizadeh as Directors of the Company and the Bank was at the recommendation of the Company’s Nominating and Governance Committee. Messrs. Girod and Zamanizadeh have not been appointed to serve on any of the Company’s, or the Bank’s committees. For further information concerning Messrs. Girod’s and Zamanizadeh’s backgrounds, reference is made to the press release dated April 2, 2026, which is attached hereto as Exhibit 99.1 and incorporated herein by reference.

There are no family relationships between Messrs. Girod and Zamanizadeh and any director or executive officer of the Company and the Bank and Messrs. Girod and Zamanizadeh were not appointed as directors pursuant to any arrangement or understanding with any person.  Messrs. Girod and Zamanizadeh have not engaged in any transaction with the Company or the Bank that would be reportable as a related party transaction under the rules of the Securities and Exchange Commission.


Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

(a) The Board of Directors has amended the Company’s Bylaws to increase the size of the Board from eight (8) to ten (10) members. A copy of the Company’s amended and restated Bylaws is attached hereto as Exhibit 3.2.

Item 9.01  Financial Statements and Exhibits.

(d)    Exhibits

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)










SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
RIVERVIEW BANCORP, INC.
 
 
Date:  April 2, 2026 
/s/ David Lam                                      
 
David Lam
 
Chief Financial Officer
(Principal Financial Officer)















From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Riverview Bancorp Inc (RVSB)

Reference

Frequently asked questions

When did Riverview Bancorp Inc file this 8-K?
Riverview Bancorp Inc (RVSB) filed this Current Report (Form 8-K) with the SEC on April 2, 2026. The accession number assigned by EDGAR is 0000939057-26-000075.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Riverview Bancorp and Riverview Bank appoint two new directors, expanding boards from eight to ten; backgrounds outlined in the press release. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Riverview Bancorp Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Riverview Bancorp Inc has filed under CIK 1041368, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer